A Multi-site Feasibility Clinical Trial of Retraining and Control Therapy (ReACT), a Mind and Body Treatment for Pediatric Functional Seizures
NCT05819268 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 108
Last updated 2026-03-17
Summary
The purpose of this study is to assess the feasibility of conducting a future fully powered multi-site efficacy Randomized Controlled Trial (RCT) comparing two treatments for pediatric functional seizures (FS). In this study, 11-18-year-olds diagnosed with FS will be randomized to 12 sessions of Retraining and Control Therapy (ReACT) or Competent Adulthood Transition with Cognitive Behavioral, Humanistic, and Interpersonal Training (CATCH-IT) at 3 sites: University of Alabama at Birmingham, Yale School of Medicine/Yale New Haven Children's Hospital and Baylor College of Medicine/Texas Children's Hospital.
Feasibility of recruitment will be measured by the percentage of planned participant enrollment target obtained at each site and overall during the 18 months of planned enrollment. Acceptability will be assessed using the Acceptability Questionnaire. Participant retention will be measured by the percent of enrolled participants that complete the 2-month follow-up visit at each site and overall. For treatment fidelity assessment, 20% of each therapist's sessions will be randomly chosen and assessed for fidelity. Patient adherence will be measured in two ways: 1) the percent of ReACT or CATCH-IT sessions completed at each site and overall and 2) for ReACT, the percent of times participants report using the treatment plan during FS episodes (measured by FS diary) and for CATCH-IT, the number of times parents and children spend using CATCH-IT each week (measured by the CATCH-IT platform). These data will be used to support a future fully-powered multi-site RCT assessing the efficacy of ReACT for pediatric FS.
Conditions
- Functional Seizures
- Convulsion, Non-Epileptic
Interventions
- BEHAVIORAL
-
ReACT
ReACT includes 12 sessions with a therapist that will discuss a plan for managing FS.
- BEHAVIORAL
-
CATCH-IT
CATCH-IT involves the parent and child completing CBT modules on the web-based CATCH-IT platform, and they will meet with a CATCH-IT coach 12 times to discuss the modules and plan how to apply this to their life and their FS.
Sponsors & Collaborators
-
Yale University
collaborator OTHER -
Baylor College of Medicine
collaborator OTHER -
National Center for Complementary and Integrative Health (NCCIH)
collaborator NIH -
University of Alabama at Birmingham
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 11 Years
- Max Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-03-18
- Primary Completion
- 2026-12-31
- Completion
- 2027-08-31
Countries
- United States
Study Locations
More Related Trials
-
Ketogenic Diet vs ACTH for the Treatment of Children With West Syndrome
NCT05279118 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2/PHASE3
-
Physical Excercise Program in Children With Drug-resistant Epilepsy
NCT05323682 ·Status: UNKNOWN ·Phase: NA
-
Pilot Trial to Evaluate The Effect of Oral Methylprednisolone on Seizure Frequency in Children With Epilepsy
NCT04219995 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Treatment Resistant Epilepsy and N-Acetyl Cysteine
NCT02054949 ·Status: WITHDRAWN ·Phase: NA
-
Continued Anticonvulsants After Resolution of Neonatal Seizures: a Patient-centered Comparative Effectiveness Study
NCT02789176 ·Status: COMPLETED
-
Decreasing Parental Stress of Caregivers of Infants With Infantile Spasms by Using Telemedicine Technology
NCT04086992 ·Status: UNKNOWN ·Phase: NA
-
Cortical Excitability in West Syndrome Using Transcranial Magnetic Stimulation
NCT06201897 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
A Taste and Acceptance Study of FruitiVits in Children Aged 4-8 Years Following a Ketogenic Diet.
NCT02229318 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety Evaluation of Hyperthermic Baths in the Treatment of Seizures in CDKL5 Deficiency Disorder
NCT06447675 ·Status: COMPLETED ·Phase: NA
-
The Potential of a Low Glutamate Diet as a Treatment for Pediatric Epilepsy
NCT04545346 ·Status: COMPLETED ·Phase: NA
-
Prevention of N-methyl-D-aspartate (NMDA) Antagonist-induced Psychosis in Kids
NCT00205712 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Magnesium Supplementation for Children With Drug Resistant Idiopathic Epilepsy
NCT02982824 ·Status: COMPLETED ·Phase: NA
-
RCT for Intermittent Versus Continuous Propofol Sedation for Pediatric Brain and Spine MRI Studies
NCT00515359 ·Status: COMPLETED ·Phase: NA
-
Predictors of Drug Resistant Epilepsy Among Pediatric Patients
NCT07241754 ·Status: NOT_YET_RECRUITING
-
Oral Baclofen Pharmacokinetics and Pharmacodynamics in Children With Spasticity
NCT00607542 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Evaluating Dietary Intervention Before surgicaL Treatment for Epilepsy
NCT02261753 ·Status: TERMINATED ·Phase: NA
-
Effectiveness of Rituximab in Pediatric OMS Patients.
NCT00244361 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Outcomes of Drug Resistant Epileptic Pediatric Patient by Modified Atkins Diet
NCT07275125 ·Status: NOT_YET_RECRUITING
-
Online Treatment Recovery Assistance for Concussion in Kids
NCT05065099 ·Status: UNKNOWN ·Phase: NA
-
Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy
NCT02216500 ·Status: RECRUITING ·Phase: NA
-
Sedation for Brainstem Evoked Auditory Response (BEAR) Testing Using Intravenous Pentobarbital
NCT01282112 ·Status: COMPLETED
-
Cellcept for Treatment of Juvenile Neuronal Ceroid Lipofuscinosis
NCT01399047 ·Status: COMPLETED ·Phase: PHASE2
-
Phase II Randomized Study of Early Surgery Vs Multiple Sequential Antiepileptic Drug Therapy for Infantile Spasms Refractory to Standard Treatment
NCT00004758 ·Status: COMPLETED ·Phase: PHASE2
-
Use of Sustained Release Antiepileptic Medication (Depakote® ER) for Pediatric Epilepsy in a Mental Retardation/Developmental Disorder Population
NCT00207935 ·Status: COMPLETED ·Phase: PHASE4
-
Modified Atkins Diet in Children and Adolescents With Drug-resistant Epilepsy
NCT01278966 ·Status: COMPLETED ·Phase: NA